Antibody Contract Development & Manufacturing Organization Market Size, Share & Trends Report

Antibody Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Product, By Source, By Therapeutic Area (Oncology, Neurology, Cardiology), By End-use, By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-4-68040-116-7
Number of Report Pages: 175
Format: PDF, Horizon Databook

Historical Range: 2018 - 2021
Forecast Period: 2023 - 2030
Industry: Healthcare

Market Segmentation

Antibody CDMO Product Outlook (Revenue, USD Million, 2018 - 2030)
- Monoclonal Antibodies
- Polyclonal Antibodies
- Others
Antibody CDMO Source Outlook (Revenue, USD Million, 2018 - 2030)
- Mammalian
- Microbial
Antibody CDMO Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Immune-mediated Disorders
- Others
Antibody CDMO End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Biopharmaceutical Companies
- Research Laboratories
- Others
Antibody CDMO Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Monoclonal Antibodies
    - Polyclonal Antibodies
    - Others
  - North America Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
    - Mammalian
    - Microbial
  - North America Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
    - Neurology
    - Cardiology
    - Infectious Diseases
    - Immune-mediated Disorders
    - Others
  - North America Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Biopharmaceutical Companies
    - Research Laboratories
    - Others
  - U.S.
    - U.S. Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - U.S. Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - U.S. Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - U.S. Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Canada
    - Canada Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Canada Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Canada Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Canada Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
- Europe
  - Europe Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Monoclonal Antibodies
    - Polyclonal Antibodies
    - Others
  - Europe Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
    - Mammalian
    - Microbial
  - Europe Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
    - Neurology
    - Cardiology
    - Infectious Diseases
    - Immune-mediated Disorders
    - Others
  - Europe Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Biopharmaceutical Companies
    - Research Laboratories
    - Others
  - UK
    - UK Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - UK Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - UK Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - UK Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Germany
    - Germany Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Germany Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Germany Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Germany Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - France
    - France Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - France Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - France Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - France Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Italy
    - Italy Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Italy Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Italy Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Italy Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Spain
    - Spain Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Spain Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Spain Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Spain Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Denmark
    - Denmark Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Denmark Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Denmark Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Denmark Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Sweden
    - Sweden Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Sweden Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Sweden Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Sweden Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Norway
    - Norway Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Norway Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Norway Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Norway Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
- Asia Pacific
  - Asia Pacific Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Monoclonal Antibodies
    - Polyclonal Antibodies
    - Others
  - Asia Pacific Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
    - Mammalian
    - Microbial
  - Asia Pacific Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
    - Neurology
    - Cardiology
    - Infectious Diseases
    - Immune-mediated Disorders
    - Others
  - Asia Pacific Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Biopharmaceutical Companies
    - Research Laboratories
    - Others
  - Japan
    - Japan Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Japan Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Japan Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Japan Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - China
    - China Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - China Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - China Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - China Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - India
    - India Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - India Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - India Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - India Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Australia
    - Australia Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Australia Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Australia Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Australia Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Thailand
    - Thailand Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Thailand Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Thailand Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Thailand Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - South Korea
    - South Korea Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - South Korea Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - South Korea Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - South Korea Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
- Latin America
  - Latin America Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Monoclonal Antibodies
    - Polyclonal Antibodies
    - Others
  - Latin America Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
    - Mammalian
    - Microbial
  - Latin America Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
    - Neurology
    - Cardiology
    - Infectious Diseases
    - Immune-mediated Disorders
    - Others
  - Latin America Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Biopharmaceutical Companies
    - Research Laboratories
    - Others
  - Brazil
    - Brazil Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Brazil Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Brazil Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Brazil Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Mexico
    - Mexico Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Mexico Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Mexico Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Mexico Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Argentina
    - Argentina Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Argentina Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Argentina Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Argentina Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
- Middle East & Africa
  - Middle East & Africa Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Monoclonal Antibodies
    - Polyclonal Antibodies
    - Others
  - Middle East & Africa Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
    - Mammalian
    - Microbial
  - Middle East & Africa Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
    - Oncology
    - Neurology
    - Cardiology
    - Infectious Diseases
    - Immune-mediated Disorders
    - Others
  - Middle East & Africa Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Biopharmaceutical Companies
    - Research Laboratories
    - Others
  - South Africa
    - South Africa Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - South Africa Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - South Africa Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - South Africa Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Saudi Arabia
    - Saudi Arabia Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Saudi Arabia Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Saudi Arabia Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Saudi Arabia Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - UAE
    - UAE Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - UAE Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - UAE Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - UAE Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others
  - Kuwait
    - Kuwait Antibody CDMO Market, By Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Monoclonal Antibodies
      - Polyclonal Antibodies
      - Others
    - Kuwait Antibody CDMO Market, By Source Outlook (Revenue, USD Million, 2018 - 2030)
      - Mammalian
      - Microbial
    - Kuwait Antibody CDMO Market, By Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
      - Oncology
      - Neurology
      - Cardiology
      - Infectious Diseases
      - Immune-mediated Disorders
      - Others
    - Kuwait Antibody CDMO Market, By End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Biopharmaceutical Companies
      - Research Laboratories
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.